The Use of Inactivated Influenza Vaccine in Children

Seminars in Pediatric Infectious Diseases

Volumn 17, Issue 4, 2006, Pages 200-205

  Wright, Peter F ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; INACTIVATED VACCINE; INFLUENZA VACCINE;

ALLERGIC ASTHMA; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; DEMYELINATING DISEASE; DRUG EFFICACY; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG SAFETY; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNOGENICITY; INFLUENZA; INFLUENZA VACCINATION; INJECTION SITE ERYTHEMA; INJECTION SITE PAIN; INJECTION SITE REACTION; INJECTION SITE SWELLING; MALAISE; MYALGIA; NONHUMAN; SYSTEMIC DISEASE; TREATMENT INDICATION; URTICARIA; VACCINATION REACTION;

ADOLESCENT; CHILD; CLINICAL TRIALS; CLINICAL TRIALS AS TOPIC; HUMANS; INFLUENZA A VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; VACCINATION; VACCINES, INACTIVATED;

EID: 33749991359     PISSN: 10451870     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.spid.2006.08.004     Document Type: Article

References (31)

1. Prevention and Control of Influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP) June 28, 2006/Vol. 55/Early Release
2. Neuzil K.M., Mellen B.G., Mitchel E.F., et al. Effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med 342 (2000) 225-231
3. Bhat N., Wright J.G., Broder K.R., et al., Influenza Special Investigations Team. Influenza-associated deaths among children in the United States, 2003-2004. N Engl J Med 15; 353 (2005) 2559-2567
4. Schrag S.J., Shay D.K., Gershman K., et al. Emerging Infections Program Respiratory Diseases Activity. Multistate surveillance for laboratory-confirmed, influenza-associated hospitalizations in children: 2003-2004. Pediatr Infect Dis J 25 (2006) 395-400
5. Neuzil K.M., Zhu Y., Griffin M.R., et al. Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study. J Infect Dis 185 (2002) 147-152
6. Poehling K.A., Edwards K.M., Weinberg G.A., et al., New Vaccine Surveillance Network. The underrecognized burden of influenza in young children. N Engl J Med 6 (2006) 31-40 355
7. Perrotta D.M., Decker M., and Glezen W.P. Acute respiratory disease hospitalizations as a measure of impact of epidemic influenza. Am J Epidemiol 122 (1985) 468-476
8. Neuzil K.M., Wright P.F., Mitchel Jr. E.F., et al. The burden of influenza illness in children with asthma and other chronic medical conditions. J Pediatr 137 (2000) 856-864
9. Boyer K.M., Cherry J.D., Wright P.F., et al. Clinical reactions and serologic responses in healthy children aged six to 35 months after two-dose regimens of inactivated A/New Jersey/76 influenza virus vaccines. J Infect Dis 136 suppl (1977) S579-S583
10. Wright P.F., Thompson J., Vaughn W.K., et al. Trials of influenza A/New Jersey/76 virus vaccine in normal children: an overview of age-related antigenicity and reactogenicity. J Infect Dis 136 suppl (1977) S731-S741
11. Lerman S.J., Wright P.F., and Patil K.D. Antibody decline in children following A/New Jersey/76 influenza virus immunization. J Pediatr 96 (1980) 271-274
12. Treanor J.J., Campbell J.D., Zangwill K.M., et al. Safety and Immunogenicity of an Inactivated Subvirion Influenza A (H5N1) Vaccine. N Engl J Med 354 (2006) 1343-1351
13. Reuben F.L. Inactivated influenza virus vaccines in children. Clin Inf Dis 38 (2004) 678-688
14. Belshe R.B., and Gruber W.C. Prevention of otitis media in children with live attenuated influenza vaccine given intranasally. Pediatr Infect Dis J 19 suppl (2000) S66-S71
15. Neuzil K.M., Dupont W.D., Wright P.F., et al. Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experience. Pediatr Infect Dis J 20 (2001) 733-740
16. Barry D.W., Mayner R.E., Hochstein H.D., et al. Comparative trial of influenza vaccines. II. Adverse reactions in children and adults. Am J Epidemiol 104 (1976) 47-59
17. France E.K., Glanz J.M., Xu S., et al. Safety of the trivalent inactivated influenza vaccine among children: a population-based study. Arch Pediatr Adolesc Med 158 (2004) 1031-1036
18. Sugaya N., Nerome K., Ishida M., et al. Efficacy of inactivated vaccine in preventing antigenically drifted influenza type A and well-matched type B. JAMA 272 (1994) 1122-1126
19. Hurwitz E.S., Haber M., Chang A., et al. Studies of the 1996-1997 inactivated influenza vaccine among children attending day care: immunologic response, protection against infection, and clinical effectiveness. J Infect Dis 182 (2000) 1218-1221
20. Colombo C., Argiolas L., La Vecchia C., et al. Influenza vaccine in healthy preschool children. Rev Epidemiol Sante Publique 49 (2001) 157-162
21. Heikkinen T., Ruuskanen O., Waris M., et al. Influenza vaccination in the prevention of acute otitis media in children. Am J Dis Child 145 (1991) 445-448
22. Clements D.A., Langdon L., Bland C., et al. Influenza A vaccine decreases the incidence of otitis media in 6- to 30-month-old children in day care. Arch Pediatr Adolesc Med 149 (1995) 1113-1117
23. Monto A.S., Davenport F.M., Napier J.A., et al. Modification of an outbreak of influenza in Tecumseh, Michigan by vaccination of schoolchildren. J Infect Dis 122 (1970) 16-25
24. Reichert T.A., Sugaya N., Fedson D.S., et al. The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med 344 (2001) 889-896
25. MMWR. Childhood Influenza Vaccination Coverage-United States, 2003-04 Influenza Season April 12, 2002 / 51(RR03);1-31
26. MMWR. Assessment of the Effectiveness of the 2003-04 Influenza Vaccine Among Children and Adults-Colorado (2003) MMWR 2003;53:MM31;707
27. Treanor J., and Wright P.F. Immune correlates of protection against influenza in the human challenge model. Dev Biol (Basel) 115 (2003) 97-104
28. Wright P.F. How do influenza vaccines work?. Clin Infect Dis 39 (2004) 928-929
29. Johnson P.R., Feldman S., Thompson J.M., et al. Immunity to influenza A virus infection in young children: a comparison of natural infection, live cold-adapted vaccine, and inactivated vaccine. J Infect Dis 154 (1986) 121-127
30. El-Madhun A.S., Cox R.J., and Haaheim L.R. The effect of age and natural priming on the IgG and IgA subclass responses after parenteral influenza vaccination. J Infect Dis 180 (1999) 1356-1360
31. Renegar K.B., Small Jr. P.A., Boykins L.G., et al. Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract. J Immunol 173 (2004) 1978-1986